Carrington receives authorization to market products covering four additional label indications.IRVING, Texas--(BUSINESS WIRE)--May 18, 1995--Carrington Laboratories, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CARN) announced today it has received marketing clearance to add four additional label claims to existing labels for a number of the company's wound dressing products. Effective immediately indications for diabetic ulcers, foot ulcers, post surgical incisions and radiation dermatitis radiation dermatitis n. See radiodermatitis. will be included on all of Carrington's topical wound dressing product labels. These same indications will be used for a new freeze dried gel wound dressing which is expected to be on the market later this year. Carrington received market clearance to modify its labels on four existing product lines. These include Carrasyn(TM) Hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. Wound Dressing, Carrasyn(TM) FDG FDG Fluorodeoxyglucose FDG Fundação de Desenvolvimento Gerencial FDG Franchise Development Group FDG Function Dependence Graph FDG Fraud Detection Group FDG Functional Dependency Gate FDG Front des Gaulois FDG Falling Down Giggling 4X4 Sterile Preservative-free Pads, Carragauze(TM) Sterile Gauze Packing Strips, and Carragauze(TM) Hydrogel Wound Dressing Saturated Pads. These products, which use the company's patented complex carbohydrate complex carbohydrate n. A polysaccharide consisting of a chain of glucose molecules; starch. technology, will now be marketed for the management of radiation dermatitis, first and second degree burns, diabetic ulcers, pressure ulcers (stages one through four), stasis stasis /sta·sis/ (sta´sis) 1. a stoppage or diminution of flow, as of blood or other body fluid. 2. a state of equilibrium among opposing forces. ulcers, foot ulcers, cuts, abrasions, irritations of the skin, post surgical incisions, and skin conditions associated with peristomal care. According to industry sources, the annual U.S. market for the management of wounds is estimated to be in excess of one billion dollars. Carrington Laboratories, Inc., has focused on the hydrogel segment of the wound care market and has about a 55 percent share of the hydrogel market. With the launch of its new freeze dried products and these added label indications, the company expects to achieve greater market penetration in the larger wound care marketplace. Carlton E. Turner, Ph.d, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "These accomplishments reflect the teamwork between the clinicians, researchers, regulatory personnel and marketing staff at Carrington. Their teamwork has gained timely marketing clearance for these label claims. These indications will allow a more effective use of Carrington's 48 member sales force." Carrington Laboratories, Inc., is an emerging research-based pharmaceutical and medical device company engaged in developing complex carbohydrate-based therapeutics and in manufacturing and marketing products for the management of wounds. CONTACT: Carrington Laboratories Inc. Jim Blackmore, 214/988-3736 Chris Record, 214/518-1300 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion